Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species

J Gastroenterol. 2006 Mar;41(3):257-68. doi: 10.1007/s00535-005-1738-1.

Abstract

Background: Hepatitis C virus (HCV) core protein is known to cause oxidative stress and alter apoptosis pathways. However, the apoptosis results are inconsistent, and the real significance of oxidative stress is not well known. The aim of this study was twofold. First, we wanted to confirm whether core-induced oxidative stress was really significant enough to cause DNA damage, and whether it induced cellular antioxidant responses. Second, we wanted to evaluate whether this core-induced oxidative stress and the antioxidant response to it was responsible for apoptosis changes.

Methods: HCV core protein was expressed under control of the Tet-Off promoter in Huh-7 cells and HeLa cells. We chose to use deoxycholic acid (DCA) as a model because it is known to produce both reactive oxygen species (ROS) and apoptosis.

Results: Core expression uniformly increased ROS and 8-hydroxy-2'-deoxyguanosine (8-OHdG) under basal and DCA-stimulated conditions. Core protein expression also increased manganese superoxide dismutase levels. Core protein inhibited DCA-mediated mitochondrial membrane depolarization and DCA-mediated activation of caspase-9 and caspase-3, despite the increase in ROS by DCA. Core protein inhibited DCA-mediated apoptosis by increasing Bcl-x(L) protein and decreasing Bax protein, without affecting the proportion of Bax between mitochondria and cytosol, resulting in suppression of cytochrome c release from mitochondria into cytoplasm.

Conclusions: HCV core protein induces oxidative DNA damage, whereas it inhibits apoptosis that is accompanied by enhancement of ROS production. Thus, oxidative stress and apoptosis modulation by core protein are independent of each other.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Antioxidants / metabolism
  • Apoptosis / drug effects*
  • Apoptosis Regulatory Proteins / drug effects
  • Apoptosis Regulatory Proteins / metabolism
  • Carcinoma, Hepatocellular / metabolism
  • Cell Line, Tumor
  • Cytochromes c / drug effects
  • Cytochromes c / metabolism
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Dactinomycin / pharmacology
  • Deoxycholic Acid / metabolism*
  • Deoxyguanosine / analogs & derivatives
  • Deoxyguanosine / metabolism
  • Enzyme Activation / drug effects
  • Humans
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / metabolism
  • Liver Neoplasms / metabolism
  • Mitochondria, Liver / drug effects*
  • Mitochondria, Liver / metabolism*
  • Oxidative Stress / drug effects
  • Protein Synthesis Inhibitors / pharmacology
  • Reactive Oxygen Species / metabolism*
  • Superoxide Dismutase / drug effects
  • Superoxide Dismutase / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • Viral Core Proteins / biosynthesis
  • Viral Core Proteins / metabolism*
  • bcl-2-Associated X Protein / metabolism
  • bcl-X Protein / metabolism

Substances

  • Antioxidants
  • Apoptosis Regulatory Proteins
  • Protein Synthesis Inhibitors
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Viral Core Proteins
  • bcl-2-Associated X Protein
  • bcl-X Protein
  • nucleocapsid protein, Hepatitis C virus
  • Deoxycholic Acid
  • Dactinomycin
  • 8-Hydroxy-2'-Deoxyguanosine
  • Cytochromes c
  • Superoxide Dismutase
  • Deoxyguanosine